Other Events ·
vTv Therapeutics adopts by-laws with exclusive federal forum for Securities Act claims
VTVTvTv Therapeutics Inc.
The Board of Directors approved the Third Amended and Restated By-Laws on October 1, 2026. Key changes include requiring stockholder director nominees to provide evidence of compliance with Rule 14a-19 five business days before a meeting, adjusting voting standards for non-director matters to a majority of votes cast, and designating U.S. federal district courts as the exclusive forum for Securities Act claims. The company is a clinical-stage biopharmaceutical firm focused on developing treatments for rare diseases.